Novopulmon 200 Novolizer contains 200 doses of beclometasone dipropionate, an inhaled corticosteroid (ICS) indicated for the prevention and long-term management of bronchial asthma and chronic obstructive pulmonary disease (COPD).
Beclometasone provides potent anti-inflammatory effects within the airways, reducing mucosal swelling, lowering bronchial hyperreactivity, and preventing asthma exacerbations.
The Novolizer® device is user-friendly, featuring dose metering, breath-controlled inhalation, and a built-in dose counter for safety and convenience. This makes it particularly suitable for long-term management of asthma and COPD.
Indications:
-
Bronchial asthma (maintenance and prophylaxis)
-
COPD (long-term therapy)
Benefits:
-
Strong anti-inflammatory action
-
Easy-to-use dry powder inhaler
-
Accurate dosing with dose counter
-
Suitable for daily long-term use
⚠️ Important notes:
-
Not intended for relief of acute attacks (not a bronchodilator)
-
Therapeutic effect develops gradually with regular use
-
To be used strictly as prescribed by a physician
Form: Dry powder inhaler with cartridge
Strength: 200 doses (200ED)
Active substance: Beclometasone dipropionate 200 mcg
Manufacturer: MEDA Pharma GmbH
